Aktieanalys

Iconovo: Successful outcome in pharmacokinetic pilot study - Redeye

{newsItem.title}

Redeye Publicerad: 31 Oct 2024 10:25

Redeye comments on Iconovo’s announcement regarding Amneal’s completed clinical pharmacokinetic pilot study (ICOres) with a successful outcome.

Länk till analysen i sin helhet: https://www.redeye.se/research/1049896/iconovo-successful-outcome-in-pharmacokinetic-pilot-study?utm_source=finwire&utm_medium=RSS

Nyheter om Iconovo

Läses av andra just nu

Om aktien Iconovo

Senaste nytt